Stone House Investment Management’s Twist Bioscience TWST Stock Holding History

Stone House Investment Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$926	Buy	+9	New	+$586	﹤0.01%	894

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Stone House Investment Management's TWST Position: Q2 2026 in Review

Stone House Investment Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 9 shares worth $926. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Stone House Investment Management held 9 shares of Twist Bioscience worth $926 as of Q2 2026.
Twist Bioscience was a new Stone House Investment Management position in Q2 2026.
Twist Bioscience made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #894 holding.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.